[Tolerance and immunogenic effect of preventive influenza vaccination in patients with chronic lung diseases].
Seventy eight patients with chronic lung diseases were once or repeatedly vaccinated against influenza with a bivalent inactivated vaccine. The vaccination was well tolerated. Systemic reactions and transitory deterioration of the lung disease were exceptional. Fourfold rise of antibodies occurred in 1/3 (H1N1) and 1/2 (H3N2) of the patients. After one year, this increase was no more demonstrable. Annual revaccination is recommended.
D000328:Adult; D000368:Aged; D000917:Antibody Formation; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D009980:Influenza A virus / Q000276:immunology; D007252:Influenza Vaccines / Q000009:adverse effects / Q000276:immunology*; D007251:Influenza, Human / Q000276:immunology* / Q000517:prevention & control; D008171:Lung Diseases / Q000276:immunology*; D008173:Lung Diseases, Obstructive / Q000276:immunology; D008297:Male; D008875:Middle Aged
D007074:Immunoglobulin G; D007252:Influenza Vaccines
Verträglichkeit und immunogene Wirkung der Influenza-Schutzimpfung bei Patienten mit chronischen Lungenkrankheiten.